Exact Sciences Corporation
EXAS · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $2,759 | $2,500 | $2,084 | $1,767 |
| % Growth | 10.4% | 19.9% | 17.9% | – |
| Cost of Goods Sold | $840 | $738 | $661 | $459 |
| Gross Profit | $1,919 | $1,762 | $1,423 | $1,308 |
| % Margin | 69.5% | 70.5% | 68.3% | 74% |
| R&D Expenses | $431 | $427 | $394 | $386 |
| G&A Expenses | $1,421 | $1,395 | $663 | $801 |
| SG&A Expenses | $1,668 | $1,620 | $1,593 | $1,663 |
| Sales & Mktg Exp. | $248 | $226 | $930 | $862 |
| Other Operating Expenses | $868 | -$70 | $29 | $115 |
| Operating Expenses | $2,967 | $1,977 | $2,016 | $2,164 |
| Operating Income | -$1,049 | -$215 | -$594 | -$856 |
| % Margin | -38% | -8.6% | -28.5% | -48.4% |
| Other Income/Exp. Net | $13 | $13 | -$39 | $13 |
| Pre-Tax Income | -$1,036 | -$202 | -$633 | -$843 |
| Tax Expense | -$7 | $2 | -$9 | -$247 |
| Net Income | -$1,029 | -$204 | -$624 | -$596 |
| % Margin | -37.3% | -8.2% | -29.9% | -33.7% |
| EPS | -5.59 | -1.13 | -3.54 | -3.48 |
| % Growth | -394.7% | 68.1% | -1.7% | – |
| EPS Diluted | -5.59 | -1.13 | -3.54 | -3.48 |
| Weighted Avg Shares Out | 184 | 180 | 176 | 171 |
| Weighted Avg Shares Out Dil | 184 | 180 | 176 | 171 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $32 | $24 | $14 | $13 |
| Depreciation & Amortization | $215 | $207 | $198 | $180 |
| EBITDA | -$789 | $29 | -$421 | -$649 |
| % Margin | -28.6% | 1.2% | -20.2% | -36.7% |